Alamar Biosciences, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ALMR | LAB | NEOG | 300289.SZ | CTKB | TXG | |
|---|---|---|---|---|---|---|
| Market cap | 1.95B | 251.09M | 2.57B | 3.24B | 762.47M | 7.80B |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -35.4 | -63.6 | 26.1 | 23.8 | 83.3 | 684.0 |
| Price/book | 6.4 | 0.5 | 1.2 | 2.0 | 2.4 | 9.3 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +27.50% | −45.30% | +84.91% | −23.42% | +22.74% | +247.07% |
| Today | +4.26% | +2.19% | +0.68% | +0.17% | +7.96% | +2.10% |
The closest companies by business and industry (Medical Devices). Prices may be delayed up to 15 min.
Latest news
All ALMR news ›Alamar Biosciences Partners with GSK on Large-Scale Proteomic Study
Published on 11/03/2026 at 06:36 pm EST - Modified on 11/03/2026 at 06:37 pm EST Alamar Biosciences said it would use its Nulisa platform to collaborate with GSK to study circulating protein signatures and disease progression. The…
FMR LLC and Abigail P. Johnson Reveal 6.9% Ownership Stake in Upstream Bio Inc
Kalkine Media On November 5, 2026, FMR LLC and Abigail P. Johnson submitted Amendment No. 3 to a Schedule 13G with the SEC, reporting their beneficial ownership of Upstream Bio Inc common stock as of October 30, 2026. FMR
Alamar Biosciences to Participate in Upcoming Investor Conferences
Fremont, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of disease, today announced the company will be participating in the…
Minerva Neurosciences, Inc reports results for the quarter ended September 30 - Earnings Summary
TradingView Minerva Neurosciences, Inc reports results for the quarter ended September 30 - Earnings Summary
Alamar Biosciences Reports Third Quarter 2026 Financial Results and Raises 2026 Revenue Guidance
FREMONT, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of disease, today reported financial results for the quarter ended…
Alamar Biosciences and Nightingale Health to Lead UK Biobank 80,000-Sample Neurodegenerative Disease Study
The study targets earlier detection, prevention and treatment of Parkinson’s disease, Alzheimer’s disease and other neurodegenerative conditions including rare dementias FREMONT, Calif. and HELSINKI, Finland, Nov. 02, 2026 (GLOBE NEWSWIRE)…
Alamar Biosciences (NASDAQ:ALMR) Price Target Raised to $36.00
Posted by Kim Johansen on Nov 4th, 2026 Alamar Biosciences (NASDAQ:ALMR – Get Free Report) had its price objective upped by analysts at TD Cowen from $34.00 to $36.00 in a research note issued on Wednesday, Benzinga reports. The firm…
Alamar Biosciences to present at UBS and Citi healthcare investor conferences in Nov-Dec 2026
Alamar Biosciences, a leader in precision proteomics, announced it will participate in the UBS Global Healthcare Conference on November 10 and Citi’s Global Healthcare Conference on December 2, 2026. The company will host a fireside chat…
Alamar Biosciences, Inc. Stock 12‑Month Price Target Raised to $37, Implies 22% Upside
Alamar Biosciences, Inc. Stock 12‑Month Price Target Raised to $36.6, Implies 21% Upside TradingView Alamar Biosciences, Inc. Stock 12‑Month Price Target Raised to $37, Implies 22% Upside - According to estimates from 5 analysts, Alamar…
Alamar Biosciences, Inc. (ALMR) Q3 2026 Earnings Call Transcript
Alamar Biosciences, Inc. (ALMR) Q3 2026 Earnings Call November 3, 2026 4:30 PM EST Yuling Luo - Co-Founder, Chairman & CEOJustin McAnear - Chief Financial Officer Daniel Brennan - TD Cowen, Research DivisionPuneet Souda - Leerink Partners…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com15
- stocktitan.net5
- themarketsdaily.com4
- manilatimes.net2
- tradingview.com2
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 35 articles, not a forecast.